Pharmaceutical care: Pharmacy involvement in prescribing in an acute-care hospital

Pharmacy World and Science

Volumn 25, Issue 2, 2003, Pages 56-64

  Galindo, Consol ^a   Olivé, Montse ^a   Lacasa, Carmen ^a   Martínez, Julio ^a   Roure, Cristina ^a   Lladó, Montse ^a   Romero, Isabel ^a   Vilà, Anna ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antibiotic prophylaxis; Cost savings; Hospital pharmacy; Pharmaceutical care; Pharmacist interventions; Pharmacoeconomics; Spain; Thromboembolic prophylaxis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL CARE; HOSPITAL COST; HOSPITAL PHARMACY; INCIDENCE; MORBIDITY; MORTALITY; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; PRESCRIPTION; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SPAIN;

ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; HOSPITAL BED CAPACITY, 300 TO 499; HUMANS; PATIENT CARE TEAM; PATIENT-CENTERED CARE; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES; PROFESSIONAL ROLE; QUALITY ASSURANCE, HEALTH CARE; SURGICAL WOUND INFECTION; THROMBOEMBOLISM;

EID: 0038035671     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023201115649     Document Type: Article

References (32)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
2. Jiménez Torres NV, Climente Martí M. Atención farmacéutica: premisa para la calidad asistencial. [Pharmaceutical care: premise for quality in caregiving.] Rev Calidad Asistencial 1998; 13: 83-90.
3. ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 1996; 53: 1713-6.
4. Hepler CD. Pharmaceutical care. Pharm World Sci 1996; 18: 233-36.
5. White SJ. Pharmaceutical care, impossible dream today? Am J Health Syst Pharm 1996; 53: 1817-20.
6. Ivey MF. Re-engineering for dramatic improvement in the medication-use process. Am J Health Syst Pharm 1995; 52: 2681-5.
7. Pérez MT, Crusat D. Impacto de un proceso de "feed-back" informativo sobre la prescripción farmacéutica. [Impact of feedback on pharmaceutical prescriptions.] Aten Primaria 1996; 18: 386-90.
8. Stern CS. Evaluating the performance of a pharmacy benefit management company. Am J Health Syst Pharm 1995; 52: 1865-78.
9. Keys WF, Goetz MC. Computer-guided academic detailing as part of a drug benefit program. Am J Health Syst Pharm 1995; 52: 2199-204.
10. Santó MM, Lacasa C, Fraile MJ et al. Programa de garantía de calidad en el servicio de farmacia del Hospital de Barcelona. [Pharmacy service quality control program at the Hospital de Barcelona.] Farm Hosp 1998; 22: 241-8.
11. Uso racional de antibióticos en los hospitales. Un proyecto para los servicios de farmacia. [Rational use of antibiotics in hospitals. A project for pharmacy services.] Farm Clin 1996; 13: 229.
12. Martínez JA, Baeza JE. Impacto de un programa de uso racional del medicamento sobre la prescripción en un área de salud. [Impact of a rational drug use program on prescriptions in a health-care area.] Aten Primaria 1996; 18: 551-9.
13. Castillo A, Martínez ML, Suárez G et al. Evaluation of pharmaceutical care provided to inpatients of a internal medicine service. Communication at 3rd Congress of the European Association of Hospital Pharmacists, Edinburgh, 1998.
14. Eisenberg JM, Koffer H, Glick HA, et al. What is the cost of nephrotoxicity associated with aminoglycosides? Ann Intern Med 1987; 107: 900-9.
15. Mutnick, A. Cost savings and avoidance from clinical interventions. Am J Health Syst Pharm 1997; 54: 392-6.
16. Weidle P, Bradley L, Gallina J, Mullins CD, Thorn D, Siegel LP. Pharmaceutical care intervention documentation program and related cost savings at a university hospital. Hosp Pharm 1999; 34: 43-52.
17. Schneider PJ, Gift MG. Cost of medication-related problems at a university hospital. Am J Health Syst Pharm 1995; 52: 2415-8.
18. Pilzer JD, Burke TG, Mutnick AH. Drug allergy assessment at university hospital and clinic. Am J Health Syst Pharm 1996; 53: 2970-5.
19. Classen DC, Pestotnik SL, Evans RS et al. Adverse drug events in hospitalized patients. JAMA 1997; 277: 301-6.
20. Classen DC, Evans RS, Pestotnik SL et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281-6.
21. Listados de procedimientos quirúrgicos del protocolo de Profilaxis Antibiótica Quirúrgica. Hospital de Barcelona, 1998.
22. DiPiro J, Martindale R, Bakst A et al. Infection in surgical patients: Effects on mortality hospitalization, and postdischarge care. Am J Health Syst Pharm 1998; 55: 777-81.
23. Listados de procedimientos. [Procedures.] Hospital de Barcelona, 1998.
24. Jiménez NV, Casabó VG, Sancho V. Manual de procedimientos para farmacocinética clínica. [Manual of procedures for clinical pharmacokinetics.] 1997; I1, VI6, VI96.
25. Berquist D. Screening and diagnosis of deep vein thrombosis pulmonary embolism. Haemostasis 1993; 23 (Suppl 1): 57-60.
26. Martínez J, Roure C, Lacasa C et al. Garantía de calidad asistencial: indicadores de actuación en la profilaxis de la enfermedad tromboembólica postquirúrgica. [Health-care quality assurance: indicators of need for postoperative thromboembolic disease prophylaxis.] Farm Clin 1997; 14: 418-29.
27. Delgado O, Hidalgo O, Marruguet M et al. Profilaxis quirúrgica: adecuación a un estándar de calidad. [Surgical prophylaxis: meeting a quality standard.] Presentation at the XLI Congress of the Sociedad Española de Farmacia Hospitalaria.
28. Quebbeman EJ, Franson TR, Whipple JE et al. Arch Surg 1985; 120: 1069-71.
29. Martínez A, Ribes JL, Castanyer B, Puigventós F, Lozano P, Jordà R, Riera M. Aminoglucósidos: identificación sistemática de candidatos a la monitorización. [Aminoglycosides: systematic identification of candidates for monitoring.] Presentation at the XLI Congress of the Sociedad Española de Farmacia Hospitalaria.
30. Pérez JL, Castillo JR, Torelló J et al. Estudio de la interención sobre la utilización de profilaxis tromboembólica. Comunicación presentada en el XLI Congreso de la Sociedad Española de Farmacia Hospitalaria, 1996.
31. Cuenca ML, Aguilar T, Desongles T et al. Cambios en la terapéutica tras la intervención del farmacéutico. [Therapy changes following pharmacist interventions.] Farm Clin 1998; 15: 76-82.
32. Prieto R, Iglesias A, Ruiz de Velasco E et al. Intervención farmacéutica en la prescripción de medicamentos. [Pharmacist interventions in drug prescribing.] Presentation at the XL Congress of the Sociedad Española de Farmacia Hospitalaria.